Table 4.
Duplicate imaging (second stage) | Odds ratio (95% CI) | P value | ||||
Joint Longitudinal Viewer encounter | 0.08 (0.01-0.81) | .03 | ||||
Anscombe residual | 3.16 (1.29-7.79) | .01 | ||||
Provider characteristics | ||||||
|
Provider history of ordering imaging studies (quartiles) | |||||
|
|
1 | Refb | Ref | ||
|
|
2 | 0.83 (0.23-3.07) | .78 | ||
|
|
3 | 3.11 (1.18-8.22) | .02 | ||
|
|
4 | 3.93 (1.42-10.94) | .009 | ||
|
Provider type | |||||
|
|
Physician | Ref | Ref | ||
|
|
Physician assistant/Nurse practitioner | 1.24 (0.61-2.51) | .56 | ||
Patient characteristics | ||||||
|
Gender | |||||
|
|
Female | Ref | Ref | ||
|
|
Male | 1.49 (0.72-3.08) | .28 | ||
|
Age (years) | |||||
|
|
<30 | Ref | Ref | ||
|
|
30-39 | 2.28 (0.98-5.34) | .06 | ||
|
|
40-49 | 0.87 (0.32-2.42) | .79 | ||
|
|
≥50 | 1.50 (0.38-5.93) | .57 | ||
|
Race | |||||
|
|
White | Ref | Ref | ||
|
|
Black or African American | 1.03 (0.48-2.18) | .95 | ||
|
|
Other | 1.57 (0.65-3.80) | .32 | ||
|
Elixhauser comorbidity score | |||||
|
|
0 | Ref | Ref | ||
|
|
1 | 0.43 (0.20-0.91) | .03 | ||
|
|
2 | 0.43 (0.15-1.21) | .11 | ||
|
|
3 and above | 0.16 (0.04-0.57) | .005 | ||
|
Fiscal month | |||||
|
|
1 | Ref | Ref | ||
|
|
2 | 1.41 (0.00-602.30) | .91 | ||
|
|
3 | 1.31 (0.00-542.59) | .93 | ||
|
|
4 | 1.43 (0.00-639.45) | .91 | ||
|
|
5 | 0.75 (0.00-290.28) | .93 | ||
|
|
6 | 1.10 (0.00-523.39) | .98 | ||
|
|
7 | 3.15 (0.01-1539.80) | .72 | ||
|
|
8 | 1.77 (0.01-819.76) | .86 | ||
|
|
9 | 4.11 (0.01-1699.58) | .65 | ||
|
|
10 | 4.41 (0.01-2011.70) | .64 | ||
|
|
11 | 1.96 (0.01-762.17) | .83 | ||
|
|
12 | 5.02 (0.01-2177.41) | .60 | ||
Consc | 0.05 (0.00-22.75) | .34 |
aAverage incremental effects are estimated from the 2-stage residual inclusion logistic regression controlling for all variables shown in the table.
bRef indicates baseline in the analysis.
cCons: Constant term in the regression.